Mucocutaneous Candidiasis

• CLINICAL_TRIALS trial_result · 2026-04-24
  Clinical Trial Update: Rituximab for Anti-cytokine Autoantibody-Associated Diseases [Phase 1]

  Phase 1 trial evaluating Rituximab for anti-cytokine autoantibody-associated diseases, including Pulmonary Alveolar Proteinosis and Severe M…

• CLINICAL_TRIALS trial_result · 2024-11-20
  Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment [Phase 3]

  Phase 3 study assessing ibrexafungerp in patients with invasive and mucocutaneous fungal diseases refractory to or intolerant of standard tr…

• CLINICAL_TRIALS trial_result · 2024-06-07
  Clinical Trial Update: CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis [Phase 2]

  Phase 2 clinical trial evaluating MAT2203 (CAMB) for chronic mucocutaneous candidiasis has completed and posted results as of 2024-06-07.